U.S. Markets closed

Weakness Seen in Alcobra (ADHD): Stock Falls 6.7%

Zacks Equity Research

Alcobra Ltd. (ADHD) saw a big move last session, as the company’s shares fell by nearly 7% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent downtrend for ADHD, as the stock is now down almost 11% in the past one-month time frame.

The biopharmaceutical company has seen a flat track record when it comes to current year estimate revisions over the past few weeks, and the consensus for earnings hasn’t been in a trend either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.

ADHD currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Investors interested in the Medical Drugs industry may consider better-ranked stocks like Ariad Pharmaceuticals Inc. (ARIA), Grifols, S.A. (GRFS) and IGI, Laboratories, Inc. (IG). All these stocks carry a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

ALCOBRA LTD ORD (ADHD): Free Stock Analysis Report


GRIFOLS SA ADS (GRFS): Free Stock Analysis Report

IGI LABORATORIES INC (IG): Free Stock Analysis Report

Zacks Investment Research